Chemoinformaics analysis of Cyclohexane,1,2,4- triethenyl
Molecular Weight | 162.276 | nRot | 3 |
Heavy Atom Molecular Weight | 144.132 | nRig | 9 |
Exact Molecular Weight | 162.141 | nRing | 1 |
Solubility: LogS | -4.928 | nHRing | 0 |
Solubility: LogP | 4.306 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 32.0423 |
nHD | 0 | BPOL | 18.0577 |
QED | 0.556 |
Synth | 4.388 |
Natural Product Likeliness | 1.594 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.004 |
Pgp-sub | 0 |
HIA | 0.006 |
CACO-2 | -4.493 |
MDCK | 0.000024 |
BBB | 0.19 |
PPB | 0.943953 |
VDSS | 1.506 |
FU | 0.00829512 |
CYP1A2-inh | 0.196 |
CYP1A2-sub | 0.899 |
CYP2c19-inh | 0.482 |
CYP2c19-sub | 0.874 |
CYP2c9-inh | 0.149 |
CYP2c9-sub | 0.384 |
CYP2d6-inh | 0.231 |
CYP2d6-sub | 0.935 |
CYP3a4-inh | 0.935 |
CYP3a4-sub | 0.676 |
CL | 1.93 |
T12 | 0.133 |
hERG | 0.015 |
Ames | 0.03 |
ROA | 0.067 |
SkinSen | 0.051 |
Carcinogencity | 0.065 |
EI | 0.955 |
Respiratory | 0.035 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.790075 |